没有监督的喘表型:将血清皮质素与临床和炎症概况相结合
Sukanya Ravindran1, Mohammed Kaleem Ullah2, Medha Karnik2
1Department of Respiratory Medicine, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru 570015, India.
Diagnostics (Basel, Switzerland)
|December 11, 2025
概括
血清内素准确诊断喘,并识别出不同的患者表型. 这种生物标志物有助于理解喘异质性和个性化治疗策略,以获得更好的患者结果.
科学领域:
- 免疫学和呼吸系统医学
- 生物标志物发现和验证
- 个性化医学在喘中的应用.
背景情况:
- 喘是一种复杂的炎症性呼吸道疾病,具有显著的异质性.
- 皮洛斯,一种因特乐金-13诱导的蛋白质,与喘的呼吸道炎症和重塑有关.
- 在成年人喘中血清环素的诊断效用和表型关联需要进一步研究.
研究的目的:
- 评估血清质素作为成人喘的诊断生物标志物.
- 探索和定义使用临床,功能和炎症数据的多维喘表型.
- 为了将血清质素水平与已识别的喘表型相关联.
主要方法:
- 根据GINA-2020指南分类的76名成年人 (25名健康人,25名中度喘患者,26名严重喘患者) 的横截面研究.
- 通过酶相关免疫吸收试验 (ELISA) 量化血清质素.
- 先进的统计分析包括ROC分析,Firth回归,DCA,GBM用于诊断准确性,PCA与k-means聚类用于表型识别.
主要成果:
- 与健康对照人群相比,喘患者的血清皮质素水平显著更高 (p < 0.01),显示出出色的诊断准确性 (AUC = 0.987).
- 血清环素被确定为喘诊断的唯一独立预测因子 (OR = 1.47,p < 0.001),通过DCA显示了强大的校准和净益.
- 主要组件分析揭示了三个不同的喘表型:集群1 (低静蛋白,良好的肺功能),集群2 (中间静蛋白,空气流量限制) 和集群3 (高静蛋白,系统性炎症升高).
结论:
- 血清内素作为一个高度可靠和准确的成人喘诊断生物标志物.
- 多维聚类成功地确定了与静素水平,炎症负担和肺功能相关的独特喘表型.
- 这些发现支持将血清环素纳入个性化喘管理策略.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K


